ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,435 | +1.2% | 1,533 | +51.5% | 0.00% | – |
| Q2 2023 | $180,251 | +17.3% | 1,012 | +8.9% | 0.00% | – |
| Q1 2023 | $153,610 | +33.7% | 929 | +28.3% | 0.00% | – |
| Q4 2022 | $114,874 | +0.8% | 724 | -3.6% | 0.00% | – |
| Q3 2022 | $114,000 | -8.1% | 751 | -0.8% | 0.00% | – |
| Q2 2022 | $124,000 | -28.3% | 757 | -3.1% | 0.00% | – |
| Q1 2022 | $173,000 | -14.4% | 781 | -7.8% | 0.00% | – |
| Q4 2021 | $202,000 | +9.8% | 847 | +7.5% | 0.00% | – |
| Q3 2021 | $184,000 | +1.7% | 788 | -9.6% | 0.00% | – |
| Q2 2021 | $181,000 | +11.0% | 872 | +9.1% | 0.00% | – |
| Q1 2021 | $163,000 | -13.8% | 799 | -8.9% | 0.00% | -100.0% |
| Q4 2020 | $189,000 | +21.9% | 877 | +2.5% | 0.00% | – |
| Q3 2020 | $155,000 | -33.2% | 856 | -32.4% | 0.00% | -100.0% |
| Q2 2020 | $232,000 | -39.3% | 1,267 | -33.1% | 0.00% | -50.0% |
| Q1 2020 | $382,000 | – | 1,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |